Literature DB >> 14612225

Differentiating moderate and severe depression using the Montgomery-Asberg depression rating scale (MADRS).

Matthias J Müller1, Hubertus Himmerich, Barbara Kienzle, Armin Szegedi.   

Abstract

BACKGROUND: MADRS cut-off scores for moderate and severe depression were estimated in relation to the Hamilton Depression Rating Scale (HAMD(17)) and the Clinical Global Impressions Scale (CGI).
METHOD: HAMD(17), MADRS, and CGI ratings from patients with major depression (DSM-IV) were analyzed (N=85). Receiver operating characteristics (ROC) curves were applied.
RESULTS: Mean age was 51.4+/-14.5 years, 69% were female. Mean MADRS scores were 23.4+/-13.2, HAMD(17), MADRS, and CGI scores were highly correlated (r>0.85; P<0.0001). Best separation between moderate and severe depression according to CGI criteria was achieved with a MADRS score of 31 (sensitivity 93.5%, specificity 83.3%). LIMITATIONS: Studies to validate severity gradations including DSM-IV or ICD-10 diagnostic severity categories are recommended.
CONCLUSIONS: Empirically based MADRS cut-off scores to separate moderate from severe depression on the basis of HAMD(17) and CGI severity ratings in patients with major depression were yielded.

Entities:  

Mesh:

Year:  2003        PMID: 14612225     DOI: 10.1016/s0165-0327(02)00120-9

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  48 in total

1.  The Validity of the Montgomery-Asberg Depression Rating Scale in an Inpatient Sample with Alcohol Dependence.

Authors:  Breanne Hobden; Melanie L Schwandt; Mariko Carey; Mary R Lee; Mehdi Farokhnia; Sofia Bouhlal; Christopher Oldmeadow; Lorenzo Leggio
Journal:  Alcohol Clin Exp Res       Date:  2017-05-22       Impact factor: 3.455

2.  Depression longitudinally mediates the association of appearance concerns to ART non-adherence in HIV-infected individuals with a history of injection drug use.

Authors:  Aaron J Blashill; Janna R Gordon; Steven A Safren
Journal:  J Behav Med       Date:  2012-11-22

3.  Tangled Up in Blue: Unraveling the Links Between Emotional Distress and Treatment Adherence in Type 2 Diabetes.

Authors:  Jeffrey S Gonzalez; Naomi S Kane; Deborah H Binko; Amit Shapira; Claire J Hoogendoorn
Journal:  Diabetes Care       Date:  2016-10-17       Impact factor: 19.112

Review 4.  Fluvoxamine versus other anti-depressive agents for depression.

Authors:  Ichiro M Omori; Norio Watanabe; Atsuo Nakagawa; Andrea Cipriani; Corrado Barbui; Hugh McGuire; Rachel Churchill; Toshi A Furukawa
Journal:  Cochrane Database Syst Rev       Date:  2010-03-17

5.  Screening for depressive symptoms in patients with unresectable lung cancer.

Authors:  S Néron; J A Correa; E Dajczman; G Kasymjanova; H Kreisman; D Small
Journal:  Support Care Cancer       Date:  2007-02-14       Impact factor: 3.603

6.  Psychosocial Features of Clinically Relevant Patient Subgroups With Serious Mental Illness and Comorbid Diabetes.

Authors:  Douglas Gunzler; Martha Sajatovic; Richard McCormick; Adam Perzynski; Charles Thomas; Stephanie Kanuch; Kristin A Cassidy; Edna Fuentes-Casiano; Neal Dawson
Journal:  Psychiatr Serv       Date:  2016-09-15       Impact factor: 3.084

7.  Symptoms of epilepsy and organic brain dysfunctions in patients with acute, brief depression combined with other fluctuating psychiatric symptoms: a controlled study from an acute psychiatric department.

Authors:  Arne E Vaaler; Gunnar Morken; Olav M Linaker; Trond Sand; Kjell A Kvistad; Geir Bråthen
Journal:  BMC Psychiatry       Date:  2009-09-30       Impact factor: 3.630

8.  Depression in lung cancer patients: is the HADS an effective screening tool?

Authors:  Lorys Castelli; Luca Binaschi; Paola Caldera; Riccardo Torta
Journal:  Support Care Cancer       Date:  2009-03-13       Impact factor: 3.603

Review 9.  Duloxetine versus other anti-depressive agents for depression.

Authors:  Andrea Cipriani; Markus Koesters; Toshi A Furukawa; Michela Nosè; Marianna Purgato; Ichiro M Omori; Carlotta Trespidi; Corrado Barbui
Journal:  Cochrane Database Syst Rev       Date:  2012-10-17

10.  Contributors to neuropsychological impairment in HIV-infected and HIV-uninfected opiate-dependent patients.

Authors:  Allison J Applebaum; Michael W Otto; Mark A Richardson; Steven A Safren
Journal:  J Clin Exp Neuropsychol       Date:  2010-11-04       Impact factor: 2.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.